- Home
- PRDO vs MNKD Comparison
PRDO vs MNKD Comparison
Compare PRDO & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRDO
- MNKD
- Stock Information
- Founded
- PRDO 1994
- MNKD 1991
- Country
- PRDO United States
- MNKD United States
- Employees
- PRDO N/A
- MNKD N/A
- Industry
- PRDO Other Consumer Services
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- PRDO Real Estate
- MNKD Health Care
- Exchange
- PRDO Nasdaq
- MNKD Nasdaq
- Market Cap
- PRDO 1.6B
- MNKD 1.6B
- IPO Year
- PRDO N/A
- MNKD 2004
- Fundamental
- Price
- PRDO $25.43
- MNKD $5.03
- Analyst Decision
- PRDO Buy
- MNKD Buy
- Analyst Count
- PRDO 1
- MNKD 6
- Target Price
- PRDO $35.00
- MNKD $8.92
- AVG Volume (30 Days)
- PRDO 705.1K
- MNKD 2.0M
- Earning Date
- PRDO 04-30-2025
- MNKD 05-07-2025
- Dividend Yield
- PRDO 2.06%
- MNKD N/A
- EPS Growth
- PRDO 0.46
- MNKD N/A
- EPS
- PRDO 2.19
- MNKD 0.10
- Revenue
- PRDO $681,263,000.00
- MNKD $285,504,000.00
- Revenue This Year
- PRDO $23.24
- MNKD $14.66
- Revenue Next Year
- PRDO $5.00
- MNKD $14.27
- P/E Ratio
- PRDO $11.54
- MNKD $50.30
- Revenue Growth
- PRDO N/A
- MNKD 43.50
- 52 Week Low
- PRDO $16.56
- MNKD $3.97
- 52 Week High
- PRDO $29.84
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- PRDO 49.05
- MNKD 37.28
- Support Level
- PRDO $24.08
- MNKD $5.16
- Resistance Level
- PRDO $25.46
- MNKD $5.28
- Average True Range (ATR)
- PRDO 0.68
- MNKD 0.15
- MACD
- PRDO 0.19
- MNKD 0.01
- Stochastic Oscillator
- PRDO 82.54
- MNKD 22.64
About PRDO Perdoceo Education Corporation
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.